Read Entire DisclaimerBAX, Baxter, Crown Equity Holdings, CRWE, Harris Corp, HRS, Key Tronic, KTCC, NASDAQ:KTCC, NYSE:BAX, NYSE:HRS, otc:crwe, Wall Street, wallstreet
Harris Corporation (NYSE:HRS), an international communications and information technology company, reported that it has been awarded a $26 million indefinite-delivery, indefinite-quantity contract to upgrade and maintain the U.S. Department of Defense Soldier Radio Waveform (SRW) for wideband tactical communications.
The U.S. government will leverage Harris’ expertise in wideband networking to add greater capabilities to the open-standard SRW waveform software and make it more widely available to U.S. forces in next-generation tactical radios.
A major advantage of advertising through online media is that a single ad campaign targets local, national and even international audiences.
Crown Equity Holdings Inc., (CRWE) offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.
CRWE’s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.
CRWE’s division CRWE AD-Services (www.crwe-adservices.com), is a full service multimedia advertising company specializing in internet marketing. It provides modern and unique advertising campaigns, dedicated to offering the most cost effective advertising solutions.
More about CRWE at www.crownequityholdings.com.
Baxter International Inc. (NYSE:BAX) reported that the FDA has approved a new 4000 IU dosage strength of ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method].
ADVATE is a full-length recombinant factor VIII (FVIII) product that is indicated for the control and prevention of bleeding episodes in patients with hemophilia A.
The new 4000 IU dosage strength provides the convenience of a single vial dosing opportunity for many adult patients, including some patients on a dosing schedule of every three days for prophylactic treatment with ADVATE.
Key Tronic Corporation (Nasdaq:KTCC) plans to report its results for the fourth quarter and year end of fiscal 2012 after market close on August 21, 2012.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE) advertises for a particular client, Crown Equity Holdings Inc. (CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE), if paid in stock, can and may sell those securities during the advertising period.